Quick Hits: New Nanoparticle Eats Plaques That Cause Heart Attacks

The “Trojan Horse” nanoparticle could lead to a potential treatment of atherosclerosis, the leading cause of death in the United States. Future clinical trials of the nanoparticle will likely reduce the risk of most types of heart attacks with limited side effects, since the nanodrug is extremely selective on what it targets. A provisional patent has been filed for the nanoparticle, and it will be marketed later this year. The results of the study were published in the current issue of Nature Nanotechnology, and can be seen here.